- ongoing, recruitingTherapeutic exploratory (Phase II)
Dasatinib and quercetin, a combination of senolytics to treat fibrotic non-alcoholic fatty liver disease; The TRUTH study
This study, called The TRUTH study, is looking at a combination of two drugs, dasatinib and quercetin, to treat a liver condition called non-alcoholic fatty liver disease (NAFLD) with scarring (fibrosis). Researchers want to see if this treatment can improve liver scarring over 21 weeks.
Netherlands - recruitingNA
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
This study looks at whether a daily pectin supplement, found in foods like citrus peel, can reduce inflammation and improve gut health in adults with a common liver condition called MASLD. Researchers want to see if it helps with overall health.
United Kingdom - recruiting
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
This study aims to develop a simple way to find liver disease commonly linked to weight and lifestyle, called MASLD (Fatty Liver Disease). We're looking at healthy volunteers and people with known MASLD to create a tool that can easily predict the condition without needing complicated tests.
United Kingdom